Understanding Participation Habits Among Plaque Psoriasis Patients
Starting soon
Conditions studied: Plaque Psoriasis
In brief
The study intends to investigate the personal experiences of plaque psoriasis patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal. The data collected from this study will help improve future outcomes for all plaque psoriasis as well as those in under-represented demographic groups.
Key facts
- Study ID
- NCT06338358
- Run by
- Power Life Sciences Inc.
- People needed
- 500
- Starts
- 2025-04-01
- Expected to finish
- 2027-04-01
- Last updated by the study team
- 2024-03-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnosed with plaque psoriasis
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
You may not qualify if…
- Refusal of consent
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
- Any serious and/or unstable pre-existing medical disorders
Where it is running
- Power Life Sciences — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.